Vetter’s Chicago Facility Ready for Pharma

Vetter, a provider of aseptic prefilled drug delivery systems, announces that its Chicago facility is ready to accept client projects. Located at the Illinois Science + Technology Park in Skokie, IL, the facility provides cGMP filling for vials, syringes, and cartridges, supporting preclinical through phase II products.

The 24,000-sq-ft Chicago facility houses cleanrooms, chemical analysis lab, microbiology lab, cGMP storage area, and administrative offices. Site manager Dr. Claudia Roth has experience designing and establishing clinical
manufacturing lines, including freeze-drying operations.

The facility is an expansion of Vetter Development Service, one of the company’s three service divisions, along with Vetter Commercial Manufacturing and Vetter Solutions. Vetter Development Service employs more than 100 personnel in Europe and the United States and supports customer products from preclinical development through market launch. Its service portfolio includes, among others, primary and secondary packaging development, process development, clinical manufacturing, regulatory affairs services, and seamless product transfer to Vetter Commercial Manufacturing. Support includes qualification and validation, engineering, microbiology lab, chemical analysis lab, materials preparation, compounding, aseptic filling, visual inspection, quality assurance, and more.

The site is staffed in large part by experienced professionals from Vetter’s German facilities. Some of these personnel will be replaced by local professionals as they are hired and trained in Vetter best practices.

“Our train-and-replace strategy underscores Vetter’s dedication to consistency and quality, which our customers trust us to deliver,” explains Vetter's Managing Director Peter Soelkner in a press release. “This approach also helps ensure a seamless transfer from Chicago to our commercial manufacturing facilities, once products reach phase III.”

For more information visit www.vetter-pharma.com.

No votes yet